Review
Molecular biology of glucocerebrosidase and the treatment of Gaucher disease
Affiliations
- PMID: 9384672
Item in Clipboard
Review
Molecular biology of glucocerebrosidase and the treatment of Gaucher disease
Cytokines Mol Ther.
1995 Sep.
Abstract
The inherited deficiency of glucocerebrosidase results in a group of sphingolipid storage disorders referred to collectively as Gaucher disease. Study of the biochemistry and cell biology of glucocerebrosidase has made possible an effective enzyme replacement therapy for the disease. Definition of the molecular genetics of glucocerebrosidase has improved diagnostic capabilities and presents the exciting possibility of a cure through gene therapy.
Similar articles
-
[Molecular genetic approaches to neurologic diseases].Rinsho Shinkeigaku. 1989 Dec;29(12):1550-3. Rinsho Shinkeigaku. 1989. PMID: 2698300 Review. Japanese.
-
[Molecular diagnosis and gene therapy for Gaucher disease].Nihon Rinsho. 1993 Sep;51(9):2300-7. Nihon Rinsho. 1993. PMID: 8411706 Japanese.
-
[Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].J Soc Biol. 2002;196(2):175-81. J Soc Biol. 2002. PMID: 12360746 Review. French.
-
Knockdown of chimeric glucocerebrosidase by green fluorescent protein-directed small interfering RNA.Genet Mol Res. 2004 Jun 30;3(2):282-7. Genet Mol Res. 2004. PMID: 15266399
-
AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease.J Gene Med. 2006 Jun;8(6):719-29. doi: 10.1002/jgm.901. J Gene Med. 2006. PMID: 16528760
Publication types
MeSH terms
Substances
Grants and funding
etc